ARTICLE | Company News
Caprion, Expergen GmbH deal
March 20, 2006 8:00 AM UTC
Caprion in-licensed CAP-232 ( TT-232) from technology transfer company Expergen for an undisclosed amount of stock and cash. The heptapeptide, which targets pyruvate kinase M2 isozyme (PKM2), has co...